I am sorry P but IF the stock is robust, as well the fundamentals, then no amount of ‘bad mouthing’ will influence any intelligent RI NOT to buy.
My question to you: would you, now knowing the hurdles faced by any spec company (especially Bio/pharma field) be a lot wiser?, and recognize that any ‘bad mouthing’ of this stock in the past, had in fact, substance?
Examples; The Vacccine story, then the Cardiocel centre count down?, the current story? ...... promise perhaps, is it now time that this ‘dog’ stock CAN turn into a ‘cash cow’.
Please consider this instead of ‘shooting’ the messenger!
Interview on the Market Herald with Wayne., page-33
-
- There are more pages in this discussion • 46 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.00 |
Change
0.800(6.06%) |
Mkt cap ! $295.9M | |||
| Open | High | Low | Value | Volume |
| $13.08 | $14.00 | $12.84 | $202.5K | 15.04K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 88 | $13.20 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.00 | 1109 | 2 |
View Market Depth
| Last trade - 16.10pm 29/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |